China Medical System (00867.HK) MSCI-ESG Rating Upgraded to AA, Reaching Global Level
HONG KONG, Dec 22, 2020 - (ACN Newswire) - On December 17, the largest index provider, Morgan Stanley Capital International (MSCI) updated a report on the ESG (Environmental, Social and Governance) rating for China Medical System Holdings Limited ("China Medical System"), a well-established, innovation-driven specialty pharma with a focus on sales & marketing in China. According to the report, China Medical System's ESG rating has been upgraded from "BBB" to "AA", surpassing 88% of companies in the global pharmaceutical industry, and symbolizing that the Company has reached a leading level among its global peers in ESG management.In the report, MSCI recognized China Medical System's outstanding performance in Corporate Governance, Corporate Behavior, Product Safety and Quality, Human Capital Development and Access to Health Care, and commented: "Leads peers in business ethics and talent management practices". MSCI also gave a positive assessment of the Company's Corporate Behavior, "China Medical System has evidence of detailed policies on business ethics and corruption".There are seven levels of the MSCI-ESG rating, from the highest to the lowest are: AAA, AA, A, BBB, BB, B an...
